The total number of employees of the Institute is 116 people, including 18 researchers, 3 PhD, 8 Candidates of Medical Science, 3 academicians, 2 Laureate of All-Russian Exhibition Centre. Researchers of the Institute of atherosclerosis are highly qualified international level specialists recognized as experts in their field. At their account more than 500 publications, mostly in international journals, with more than 30 patents and licenses. During the work of the Institute of Atherosclerosis 3 doctoral and 13 master's theses have been received. Our staff reported results of their researches in 39 Russian and 57 international scientific congresses, conferences and symposia.

Specialists of the Institute are known among scientists all over the world for their atherosclerosis studies. It is not surprising that many foreign pharmaceutical companies appeal to the experts of the Institute for Atherosclerosis Research with proposals to test their drugs. We have well-established methodology for assessing the effectiveness of various anti-atherosclerotic agents, which allows to conduct laboratory and clinical researches at the highest level, including studies concerning standards GLP (Good Laboratory Practice) and GCP (Good Clinical Practice) for further consideration of the results of FDA (Food and Drug Administration).